Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues-Reference-Cited by-同舟云学术

Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues

Published:2015-10 Issue:10 Volume:23 Page:1641-1652
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Koski Anniina,Bramante Simona,Kipar Anja,Oksanen Minna,Juhila Juuso,Vassilev Lotta,Joensuu Timo,Kanerva Anna,Hemminki Akseli

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma;Andtbacka;J Clin Oncol,2013

2. [Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus];Xia;Ai Zheng,2004

3. Clinical development directions in oncolytic viral therapy;Eager;Cancer Gene Ther,2011

4. Clinical trials with oncolytic adenovirus in China;Yu;Curr Cancer Drug Targets,2007

5. Trial Watch: Oncolytic viruses for cancer therapy;Pol;Oncoimmunology,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial;Clinical Cancer Research;2024-03-27

2. Long-term antigen-specific immune response by an oncolytic adenovirus encoding SP-SA-E7-4-1BBL in HPV-16 cancer model;Molecular Biology Reports;2024-03-09

3. Predicting the Abscopal Phenomenon—Letter to the Editor;Molecular Cancer Therapeutics;2024-02-01

4. Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1;OncoImmunology;2022-01-22

5. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses;Future Oncology;2022-01